Funding
Co-Investigator MRC Research Grant (2015-2019)
MRC New Investigator Research Grant Holder (present)
Research groups
Colleges
Collaborators
-
David Bennett
Professor of Neurology and Neurobiology
-
Sarosh Irani
Collaborator, Oxford Autoimmune Neurology Group
John Dawes
Associate Professor
- Principal Investigator
- Course Director, MSc Pain Neurosciences
Research Summary
It is now well established that the immune system contributes to pathological pain sates and one relatively under studied aspect of this is through the action of autoantibodies. Neuropathic pain is common in patients with autoantibodies directed against components of the voltage gated potassium channel complex such as CASPR2 and LGI1. By using patient samples in combination with basic pain research my aim is to better understand the mechanisms of autoantibody mediated pain and by doing so uncover novel molecular pathways regulating pain sensitivity as well as revealing clinically relevant targets for the development of future therapies.
Key publications
-
A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity
Journal article
Farah A. et al, (2024), Brain
-
Autoantibodies as drivers of neuropathic pain.
Journal article
Farah A. et al, (2025), Trends Mol Med
-
A role for pathogenic autoantibodies in small fiber neuropathy?
Journal article
Daifallah O. et al, (2023), Frontiers in Molecular Neuroscience, 16
-
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability
Journal article
Dawes JM. et al, (2018), Neuron, 97, 806 - 822.e10
-
Autoantibodies and neuropathic pain
Chapter
Dawes JM. and Bennett DL., (2018), The Oxford Handbook of the Neurobiology of Pain, 833 - 850
Recent publications
-
Specific overexpression of contactin-associated protein-like 2 and its effects on pain-related behaviour in mice
Journal article
Tseng M. et al, (2025), PAIN Reports, 10, e1309 - e1309
-
Autoantibodies as drivers of neuropathic pain.
Journal article
Farah A. et al, (2025), Trends Mol Med
-
Immunotherapy‐Resistant Neuropathic Pain and Fatigue Predict Quality‐of‐Life in Contactin‐Associated Protein‐Like 2 Antibody Disease
Journal article
Ceronie B. et al, (2025), Annals of Neurology, 97, 521 - 528
-
A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity
Journal article
Farah A. et al, (2024), Brain
-
Antibody-mediated autoimmunity in symptom-based disorders: position statement and proceedings from an international workshop.
Journal article
Mountford R. et al, (2024), Pain Rep, 9